Reports for SIVEM PHARMACEUTICALS ULC
Company Name
SIVEM PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
378 |
|
| Actual shortage: | 25 (7%) | |
| Anticipated shortage: | 6 (2%) | |
| Avoided shortage: | 14 (4%) | |
| Resolved: | 333 (88%) | |
Discontinuation Reports |
107 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 100 (93%) | |
| Reversed: | 7 (7%) | |
Late reports |
83 (17%) |
|
Overdue reports |
6 (19%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LAMOTRIGINE | 100MG | TABLET | Resolved | 2019-12-12 | 2020-02-27 | 101103 |
| ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-05 | 2017-11-03 | 5614 |
| ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-05 | 2017-11-03 | 5617 |
| IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2019-04-01 | 2019-05-06 | 80252 |
| IRBESARTAN HCT | 150MG 12.5MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126600 |
| IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2018-11-12 | 2018-12-29 | 66698 |
| IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2019-04-22 | 2019-06-22 | 82135 |
| IRBESARTAN HCT | 300MG 12.5MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126603 |
| IRBESARTAN HCT | 300MG 25MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126606 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-11-12 | 2018-12-21 | 66689 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-12-21 | 2019-02-22 | 70366 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-04-01 | 2019-07-06 | 80246 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126591 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2023-11-22 | 2024-04-01 | 211146 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2018-11-12 | 2018-12-21 | 66692 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2018-12-21 | 2019-02-22 | 70369 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2019-05-06 | 2019-05-31 | 83165 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126594 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2018-11-12 | 2018-12-21 | 66695 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2019-04-01 | 2019-05-31 | 80249 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATORVASTATIN-20 | 20MG | TABLET | Discontinued | 2019-01-03 | 2019-06-10 | 70941 |
| ATORVASTATIN-10 | 10MG | TABLET | Discontinued | 2019-01-03 | 2019-05-31 | 70938 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53291 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53294 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53297 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53300 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53303 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53306 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53318 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53321 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53324 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53327 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-10-22 | 53330 |
| ATENOLOL | 25MG | TABLET | Discontinued | 2017-06-06 | 2017-12-12 | 11977 |
| ATENOLOL | 25MG | TABLET | Discontinued | 2017-11-06 | 2017-11-07 | 28199 |
| ATENOLOL | 25MG | TABLET | Discontinued | 2017-11-06 | 2017-11-07 | 28202 |
| ATENOLOL | 50MG | TABLET | Discontinued | 2019-01-03 | 2019-05-31 | 70935 |
| AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2017-06-06 | 2017-06-07 | 12022 |
| AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2017-06-06 | 2017-06-07 | 12025 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2017-06-06 | 2017-06-07 | 12028 |